MSB 0.52% 96.5¢ mesoblast limited

Cell Therapy News/Articles, page-16994

  1. 12,314 Posts.
    lightbulb Created with Sketch. 1100
    This face to face meeting was attended in person by the company (Dr Itescu and others) and Dr. Nicole Verdun – being the newly appointed permanent Director of the FDA’s Centre for Biologics Evaluation and Research Office Of Therapeutic Products. The presence of senior leadership from the FDA is an encouraging sign of the intent of the Agency to facilitate an approval for Remestemcel-L

    I think they are going for home base without selling the farm.
    Its now up to Jane Bell it seems.

    Aloha.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
96.5¢
Change
-0.005(0.52%)
Mkt cap ! $1.107B
Open High Low Value Volume
98.0¢ 98.5¢ 96.0¢ $1.147M 1.179M

Buyers (Bids)

No. Vol. Price($)
31 191842 96.0¢
 

Sellers (Offers)

Price($) Vol. No.
96.5¢ 39535 13
View Market Depth
Last trade - 11.52am 13/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.